Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Consolidated Net Income (2022 - 2026)

Cannabis Bioscience International Holdings' Consolidated Net Income history spans 5 years, with the latest figure at -$104035.0 for Q1 2026.

  • On a quarterly basis, Consolidated Net Income rose 31.42% to -$104035.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$532943.0, a 76.64% decrease, with the full-year FY2025 number at -$557627.0, down 12.17% from a year prior.
  • Consolidated Net Income hit -$104035.0 in Q1 2026 for Cannabis Bioscience International Holdings, down from -$99107.0 in the prior quarter.
  • Over the last five years, Consolidated Net Income for CBIH hit a ceiling of $18270.0 in Q2 2024 and a floor of -$324655.0 in Q1 2023.
  • Historically, Consolidated Net Income has averaged -$152913.5 across 5 years, with a median of -$127871.0 in 2025.
  • Biggest five-year swings in Consolidated Net Income: skyrocketed 106.62% in 2024 and later plummeted 1400.76% in 2025.
  • Tracing CBIH's Consolidated Net Income over 5 years: stood at -$219886.0 in 2022, then surged by 57.02% to -$94512.0 in 2023, then rose by 27.7% to -$68328.0 in 2024, then crashed by 45.05% to -$99107.0 in 2025, then dropped by 4.97% to -$104035.0 in 2026.
  • Business Quant data shows Consolidated Net Income for CBIH at -$104035.0 in Q1 2026, -$99107.0 in Q4 2025, and -$92152.0 in Q3 2025.